Article information
Full text is only aviable in PDF
REFERENCES
[1]
P Girard, D Musset, F Parent, S Maitre, C Phlippoteau, G Simonneau.
High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism.
Chest, 116 (1999), pp. 903-908
[2]
M Monreal, J Ruiz, M Fraile, M Bonet, E Davant, J Muchart, et al.
Prospective study on the usefulness of lung scan in patients with deep vein thrombosis of the lower limbs.
Thromb Haemost, 85 (2001), pp. 771-774
[3]
RH White.
The epidemiology of venous thromboembolism.
Circulation, 107 (2003), pp. I4-I8
[4]
JA Heit, WM O'Fallon, TM Petterson, CM Lohse, MD Silverstein, DN Mohr, et al.
Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study.
Arch Intern Med, 162 (2002), pp. 1245-1248
[5]
HT Sorensen, L Mellemkjaer, FH Steffensen, JH Olsen, GL Nielsen.
The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism.
N Engl J Med, 338 (1998), pp. 1169-1173
[6]
MA Crowther, JG Kelton.
Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system.
Ann Intern Med, 138 (2003), pp. 128-134
[7]
MM Samama, OE Dahl, DJ Quinlan, P Mismetti, N Rosencher.
Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool.
Haematologica, 88 (2003), pp. 1410-1421
[9]
E Pérez-Rodríguez, D Jiménez, G Díaz, I Pérez-Walton, M Luque, C Guillén, et al.
Incidence of air travel-related pulmonary embolism at the Madrid-Barajas airport.
Arch Intern Med, 163 (2003), pp. 2766-2770
[10]
J Mateo, A Oliver, M Borrell, N Sala, J Fontcuberta, the EMET Group.
Laboratory evaluation and clinical characteristics of 2132 consecutive unselected patients with venous thromboembolism. Results of the Spanish Multicentric Study on Thrombophilia (EMET study).
Thromb Haemost, 77 (1997), pp. 444-451
[11]
JC Souto, I Coll, D Llobet, E Del Río, A Oliver, J Mateo, et al.
The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population.
Thromb Haemost, 80 (1998), pp. 366-369
[12]
WH Geerts, JA Heit, GP Clagett, GF Pineo, CW Colwell, FA Anderson Jr, et al.
Prevention of venous thromboembolism.
Chest, 119 (2001), pp. 132-175
[13]
PD Stein, JW Henry.
Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy.
Chest, 108 (1995), pp. 978-981
[14]
PD Stein, ML Terrin, CA Hales, HI Palevsky, AH Satzman, T Thompson, et al.
Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease.
Chest, 100 (1991), pp. 598-603
[15]
DF Worsley, A Alavi, JM Aronchick, JT Chen, RH Greenspan, CE Ravin, et al.
Chest radiographic findings in patients with acute pulmonary embolism: Observations from the PIOPED study.
Radiology, 189 (1993), pp. 133-136
[16]
M Miniati, R Prediletto, B Formichi, C Marini, G Di Rocco, L Tonelli, et al.
Accuracy of clinical assessment in the diagnosis of pulmonary embolism.
Am J Respir Crit Care Med, 159 (1999), pp. 864-871
[17]
J Kelly, BJ Hunt.
The utility of pretest probability assessment in patients with clinically suspected venous thromboembolism.
J Thromb Haemost, 1 (2003), pp. 1888-1896
[18]
PS Wells, DR Anderson, M Rodger, JS Ginsberg, C Kearon, M Gent, et al.
Derivation of a simple clinical model to categorize patients' probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer.
Thromb Haemost, 83 (2000), pp. 416-420
[19]
J Wicki, TV Perneger, AF Junod, H Bounameaux, A Perrier.
Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score.
Arch Intern Med, 161 (2001), pp. 92-96
[20]
JA Kline, RD Nelson, RE Jackson, DM Courtney.
Criteria for the safe use of D-dimer testing in emergency department patients with suspected pulmonary embolism: a multicenter US study.
Ann Emerg Med, 39 (2002), pp. 144-152
[21]
M Miniati, S Monti, M Bottai.
A structured clinical model for predicting the probability of pulmonary embolism.
Am J Med, 114 (2003), pp. 173-179
[22]
SD Chunilal, JW Eikelboom, J Attia, M Miniati, AA Panju, DL Simel, et al.
Does this patient have pulmonary embolism?.
JAMA, 290 (2003), pp. 2849-2858
[23]
I Chagnon, H Bounameaux, D Anjosky, PM Roy, AL Gourdier, J Cornuz, et al.
Comparison of two clinical prediction rules and implicit assessment among patients with suspected pulmonary embolism.
Am J Med, 113 (2002), pp. 269-275
[24]
J Kelly, A Rudd, RG Lewis, BJ Hunt.
Plasma D-dimers in the diagnosis of venous thromboembolism.
Arch Intern Med, 162 (2002), pp. 747-756
[25]
MD Brown, BH Rowe, MJ Reeves, JM Bermingham, SZ Goldhaber.
The accuracy of the enzyme-linked immunosorbent assay D-dimer test in the diagnosis of pulmonary embolism: a meta-analysis.
Ann Emerg Med, 40 (2002), pp. 1 13-1 44
[26]
MD Brown, J Lau, RD Nelson, JA Kline.
Turbidimetric D-dimer test in the diagnosis of pulmonary embolism: a metaanalysis.
Clin Chem, 49 (2003), pp. 1783-1784
[27]
JS Ginsberg, PS Wells, C Kearon, D Anderson, M Crowther, JI Weitz, et al.
Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolism.
Ann Intern Med, 129 (1998), pp. 1006-1011
[28]
PS Wells, DR Anderson, M Rodger, I Stiell, JF Dreyer, D Barnes, et al.
Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients presenting to the Emergency Department by using a simple clinical model and D-dimer.
Ann Intern Med, 135 (2001), pp. 98-107
[29]
MG Leclercq, JG Lutisan, M van Marwijk Kooy, BF Kuipers, AHJ Oostdijk, JJCM Van der Leur, et al.
Ruling out clinically suspected pulmonary embolism by assessment of clinical probability and d-dimer levels: a management study.
Thromb Haemost, 89 (2003), pp. 97-103
[30]
JE Schrecengost, RD LeGallo, JC Boyd, KGM Moons, SL Gonias, CE Rose Jr, et al.
Comparison of diagnostic accuracies in outpatients and hospitalized patients of D-dimer testing for the evaluation of suspected pulmonary embolism.
Clin Chem, 49 (2003), pp. 1483-1490
[31]
SW Rathbun, GE Raskob, TL Whitsett.
Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review.
Ann Intern Med, 132 (2000), pp. 227-232
[32]
UJ Schoepf, P Costello.
CT angiography for diagnosis of pulmonary embolism: state of the art.
Radiology, 230 (2004), pp. 329-337
[33]
PD Stein, JW Henry.
Prevalence of acute pulmonary embolism in central and subsegmental pulmonary arteries and relation to interpretation of ventilation/perfusion lung scans.
Chest, 111 (1997), pp. 1246-1248
[34]
W de Monye, MJ van Strijen, MV Huisman, GJ Kieft, PM Pattynama.
Suspected pulmonary embolism: prevalence and anatomic distribution in 487 consecutive patients. Advances in New Technologies Evaluating the Localization of Pulmonary Embolism (ANTELOPE) Group.
Radiology, 215 (2000), pp. 184-188
[35]
T Powell, NL Müller.
Imaging of acute pulmonary thromboembolism: should spiral computed tomography replace the ventilation-perfusion scan?.
Clin Chest Med, 24 (2003), pp. 29-38
[36]
The PIOPED Investigators.
Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED).
JAMA, 263 (1990), pp. 2753-2759
[37]
M Miniati, M Pistolesi, C Marini, G di Ricco, B Formichi, R Prediletto, et al.
Value of perfusion lung scan in the diagnosis of pulmonary embolism: results of the Prospective Investigative Study of Acute Pulmonary Embolism Diagnosis (PISA-PED).
Am J Respir Crit Care Med, 154 (1996), pp. 1387-1393
[38]
MM Webber, AS Gomes, D Roe, RL la Fontaine, RA Hawkins.
Comparison of Biello, McNeil, and PIOPED criteria for the diagnosis of pulmonary emboli on lung scans.
AJR Am J Roentgenol, 154 (1990), pp. 975-981
[39]
AWA Lensing, HR Büller.
Objective tests for the diagnosis of venous thrombosis.
Disorders of thrombosis, pp. 239-257
[40]
F Turkstra, PMM Kuijer, EJR van Beek, DPM Brandjes, JW Ten Cate, HR Büller.
Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism.
Ann Intern Med, 126 (1997), pp. 775-781
[41]
PA Loud, DS Katz, DA Bruce, DL Klippenstein, ZD Grossman.
Deep venous thrombosis with suspected pulmonary embolism: detection with combined CT venography and pulmonary angiography.
Radiology, 219 (2001), pp. 498-502
[42]
SZ Goldhaber.
Echocardiography in the management of pulmonary embolism.
Ann Intern Med, 136 (2002), pp. 691-700
[43]
PD Stein, PK Woodard, RD Hull, F Kayali, JG Weg, RE Olson, et al.
Gadolinium-enhanced magnetic resonance angiography for detection of acute pulmonary embolism: an in-depth review.
Chest, 124 (2003), pp. 2324-2328
[44]
PD Stein, JW Henry, A Gottschalk.
Reassessment of pulmonary angiography for the diagnosis of pulmonary embolism: relation of interpreter agreement to the order of the involved pulmonary arterial branch.
Radiology, 210 (1999), pp. 689-691
[45]
MJHA Kruip, MGL Leclerq, C van der Heul, MH Prins, HR Büller.
Diagnostic strategies for excluding pulmonary embolism in clinical outcome studies. A systematic review.
Ann Intern Med, 138 (2003), pp. 941-951
[46]
A Perrier, S Desmarais, MJ Miron, P de Moerloose, R Lepage, D Slosman, et al.
Non-invasive diagnosis of venous thromboembolism in outpatients.
Lancet, 353 (1999), pp. 190-195
[47]
A Perrier, PM Roy, D Aujesky, I Chagnon, N Howarth, AI Gourdier, et al.
Diagnosing pulmonary embolism in outpatients with clinical assessment, D-Dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study.
Am J Med, 116 (2004), pp. 291-299
[48]
A Perrier, MR Nendaz, FP Sarasin, N Howarth, H Bounameaux.
Cost-effectiveness analysis of diagnostic strategies for suspected pulmonary embolism including helical computed tomography.
Am J Respir Crit Care Med, 167 (2003), pp. 39-44
[49]
RD Hull, GE Raskob, G Coates, AA Panju.
Clinical validity of a normal perfusion lung scan in patients with suspected pulmonary embolism.
Chest, 97 (1990), pp. 23-26
[50]
D Musset, F Parent, G Meyer, S Maitre, P Girard, C Leroyer, et al.
Evaluation du Scanner Spirale dans l'Embolie Pulmonaire study group. Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicentre outcome study.
Lancet, 360 (2002), pp. 1914-1920
[51]
SZ Goldhaber, CG Elliot.
Acute pulmonary embolism. Part II. Risk stratification, treatment, and prevention.
Circulation, 108 (2003), pp. 2834-2838
[52]
JA Kline, J Hernández-Nino, CD Newgard, DN Cowles, RE Jackson, DM Courtney.
Use of pulse oximetry to predict in-hospital complications in normotensive patients with pulmonary embolism.
Am J Med, 115 (2003), pp. 203-208
[53]
N Kucher, CM Luder, T Dörnhöfer, S Windecker, B Meier, OM Hess.
Novel management strategy for patients with suspected pulmonary embolism.
Eur Heart J, 24 (2003), pp. 366-376
[54]
J Wicki, A Perrier, TV Perneger, H Bounameaux, AF Junod.
Predicting adverse outcome in patients with acute pulmonary embolism: a risk score.
Thromb Haemost, 84 (2000), pp. 548-552
[55]
P Pruszczyk, A Bochowicz, A Torbicki, M Szulc, M Kurzyna, A Fijalkowska, et al.
Cardiac troponin T monitoring identifies high-risk group of normotensive patients with acute pulmonary embolism.
Chest, 123 (2003), pp. 1947-1952
[56]
N Kucher, G Printzen, SZ Goldhaber.
Prognostic role of brain natriuretic peptide in acute pulmonary embolism.
Circulation, 107 (2003), pp. 2545-2547
[57]
PS Wells, MA Forgie, M Simms, A Greene, D Touchie, G Lewis, et al.
The outpatient bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.
Arch Intern Med, 163 (2003), pp. 917-920
[58]
GS Landefeld, McGuire E III, MW Rosenblatt.
A bleeding risk index for estimating the probability of major bleeding in hospitalised patients starting anticoagulant therapy.
Am J Med, 89 (1990), pp. 569-578
[59]
KM Mikkola, SR Patel, JA Parker, F Grodstein, SZ Goldhaber.
Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis.
Am Heart J, 134 (1997), pp. 69-72
[60]
RD Hull, GE Raskob, RF Brant, GF Pineo, KA Valentine.
The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence.
Arch Intern Med, 157 (1997), pp. 2317-2321
[61]
S Eichinger, A Weltermann, E Minar, M Stain, V Schönauer, B Schneider, et al.
Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism.
Arch Intern Med, 164 (2004), pp. 92-96
[62]
J Hirsh, TE Warkentin, SG Shaghnessy, SS Anand, JL Halperin, R Raschke, et al.
Heparin and low-molecular-weight heparin. Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy and safety.
Chest, 119 (2001), pp. 64S-94S
[63]
DJ Quinlan, A McQuillan, JW Eikelboom.
Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism. A meta-analysis of randomized, controlled trials.
Ann Intern Med, 140 (2004), pp. 175-183
[64]
SM Arcasoy, A Vachani.
Local and systemic thrombolytic therapy for acute venous thromboembolism.
Clin Chest Med, 24 (2003), pp. 73-91
[65]
The Matisse Investigators.
Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.
N Engl J Med, 349 (2003), pp. 1695-1702
[66]
JS Ginsberg, SD Berkowitz, H Bounameaux, BL Davidson, H Eriksson, JN Fiessinger, the THRIVE Treatment Study, et al.
Efficacy and safety of the oral direct thrombin inhibitor ximelagatran compared with current standard therapy for acute, symptomatic deep vein thrombosis, with or without pulmonary embolism: the THRIVE treatment study [abstract].
Blood, (2003), pp. 102
[67]
H Decousus, A Leizorovicz, F Parent, Y Page, B Tardy, P Girard, et al.
A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.
N Engl J Med, 338 (1998), pp. 409-415
[68]
MA de Gregorio, P Gamboa, MJ Gimeno, B Madariaga, R Tobio, M Herrera, et al.
The Günther tulip retrievable filter: prolonged temporary filtration by frequent percutaneous repositioning within the inferior vena cava: results of a multicenter study.
JVIR, 14 (2003), pp. 1259-1265
[69]
MA de Gregorio, MJ Gimeno, A Mainar, M Herrera, R Tobio, R Alfonso, et al.
Mechanical and enzymatic thrombolysis for massive pulmonary embolism.
JVIR, 13 (2002), pp. 163-169
[70]
JD Douketis, GA Foster, MA Crowther, MH Prins, JS Ginsberg.
Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy.
Arch Intern Med, 160 (2000), pp. 3431-3436
[71]
T Baglin, R Luddington, K Brown, C Baglin.
Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study.
Lancet, 362 (2003), pp. 523-526
[72]
JA Heit, DN Mohr, MD Silverstein, TM Petterson, WM O'Fallon, LJ Melton.
Predictors of recurrence after deep vein thrombosis and pulmonary embolism. A population-based cohort study.
Arch Intern Med, 160 (2000), pp. 761-768
[73]
AY Lee, MN Levine.
Venous thromboembolism and cancer: risks and outcomes.
Circulation, 107 (2003), pp. 117-121
[74]
P Prandoni, AWA Lensing, MA Prins, E Bernardi, A Marchiori, P Bagatella, et al.
Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism.
Ann Intern Med, 137 (2002), pp. 955-960
[75]
G Palareti, C Legnani, B Cosmi, G Guazzaloca, C Pancani, S Coccheri.
Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
Thromb Haemost, 87 (2002), pp. 7-12
[76]
S Eichinger, E Minar, C Bialonczyk, M Hirsch, P Quehenberger, B Schneider, et al.
D-dimer levels and risk of recurrent venous thromboembolism.
JAMA, 290 (2003), pp. 1071-1074
[77]
L Pinède, P Duhaut, M Cucherat, J Ninet, J Pasquier, JP Boissel.
Comparison of long versus short duration of anticoagulant therapy after a first episode of venous thromboembolism: a meta-analysis of randomised, controlled trials.
J Intern Med, 247 (2000), pp. 553-562
[78]
CJJ van Dongen, R Vink, B Hutten, HR Büller, MH Prins.
The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis.
Arch Intern Med, 163 (2003), pp. 1285-1293
[79]
G Agnelli, P Prandoni, C Becattini, M Silingardi, MR Taliani, M Miccio, et al.
Extended oral anticoagulant therapy after a first episode of pulmonary embolism.
Ann Intern Med, 139 (2003), pp. 19-25
[80]
C Kearon, M Gent, J Hirsh, J Weitz, MJ Kovacs, DR Anderson, et al.
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
N Engl J Med, 340 (1999), pp. 901-907
[81]
PM Ridker, SZ Goldhaber, E Danielson, Y Rosenberg, CS Eby, SR Deitch, et al.
Long-term, low-intensity warfarin therapy for the prevention recurrent venous thromboembolism.
N Engl J Med, 348 (2003), pp. 1425-1434
[82]
C Kearon, JS Ginsberg, MJ Kovacs, DR Anderson, P Wells, JA Julian, et al.
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.
N Engl J Med, 349 (2003), pp. 631-639
[83]
S Schulman, S Granqvist, M Holmström, A Carlsson, P Lindmarker, P Nicol, et al.
The duration of oral anticoagulant therapy after a second episode of venous thromboembolism.
N Engl J Med, 336 (1997), pp. 393-398
[84]
LA Linkins, PT Choi, JD Douketis.
Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis.
Ann Intern Med, 139 (2003), pp. 893-900
[85]
G Meyer, Z Marjanovic, J Valcke, B Lorcerie, Y Gruel, P Solal-Celigny, et al.
Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer.
Arch Intern Med, 162 (2002), pp. 1729-1735
[86]
AYY Lee, MN Levine, RI Baker, C Bowden, AK Kakkar, M Prins, et al.
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.
N Engl J Med, 349 (2003), pp. 146-153
[87]
A Iorio, F Guercini, M Pini.
Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants.
J Thromb Haemost, 1 (2003), pp. 1906-1913
[88]
L Wawrzynska, WZ Tomkowski, J Przedlacki, B Hajduk, A Torbicki.
Changes in bone density during long-term administration of low-molecular-weight heparins or acenocoumarol for secondary prophylaxis of venous thromboembolism.
Pathophysiol Haemost Thromb, 33 (2003), pp. 64-67
[89]
S Schulman, K Wählander, T Lundström, SB Clason, H Eriksson, for the THRIVE III Investigators.
Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran.
N Engl J Med, 349 (2003), pp. 1713-1721
Copyright © 2004. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
